why choose us

Clinical Trials Search

Showing 10,800 of 132,366 result(s)
A Clinical Study of ONCT-534 in Subjects With Metastatic Castration-resistant Prostate Cancer.

Status: Completed

Condition: Metastatic Castration-resistant Prostate Cancer

Interventions: ONCT-534 is a dual-action androgen receptor inhibitor (DAARI) with a novel mechanism of action that includes inhibition of AR function and degradation

Date: 2023-06-07

Investigating Dynamic Interactions in Distributed Cognitive Control Networks

Status: Completed

Condition: Cognitive Impairment

Interventions: Passive testing includes baseline recordings or behavioral tasks without stimulation.
Examples include language tasks, cognitive, and motor tasks

Date: 2023-06-07

ORB-011 In Patients With Advanced Solid Tumors

Status: Completed

Condition: Advanced Solid Cancer

Interventions: Drug: ORB-011 is dosed via IV infusion

Date: 2023-06-07

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

Status: Completed

Condition: Cutaneous Melanoma

Interventions: Supervised pedaling on an ergometer (stationary bike) at a moderate pace for a goal of 30 minutes.
The exercise test will be scheduled at infusio

Date: 2023-06-06

NAVAH Impact on Radiation Therapy Completion in Black Breast & Prostate Cancer Patients

Status: NOT_YET_RECRUITING

Condition: Breast Cancer

Interventions: Patient navigator program that aims to inform African-American prostate and breast cancer patients about their treatment options, specifically radioth

Date: 2023-06-06

The Effects of Dietary Erythritol on Platelet Reactivity and Vascular Inflammation

Status: Completed

Condition: Platelet Aggregation, Spontaneous

Interventions: Erythritol is a naturally occurring and non-nutritive sugar alcohol that is classified as generally recognized as safe (GRAS)

Date: 2023-06-06

Limited English Proficiency Virtual Family-Centered Rounds

Status: Completed

Condition: Pediatric Disorder

Interventions: The care team will use a computer with a speaker camera, mounted on a stand with wheels to launch telehealth visits using the application ExtendedCare

Date: 2023-06-06

This Study is Evaluating a New Radiation Treatment Technique for Patients Who Have Had Prostate Cancer, Undergone Surgery for Cancer, and Then Have Evidence That Their Prostate Cancer Has Returned.

Status: NOT_YET_RECRUITING

Condition: Recurrent Prostate Cancer After Surgery

Interventions: Daily-adaptive radiation therapy to two dose levels - one to the area of radiologic recurrent nodal disease, and a lower, prophylactic dose to the sta

Date: 2023-06-06

Lurbinectedin in FET-Fused Tumors

Status: Completed

Condition: Ewing Sarcoma

Interventions: Lurbinectedin will be administered on a Day 1, Day 4 schedule every 21 days.
Doses will be determined in the phase 1 portion of the trial.

Date: 2023-06-06

Post-operative Thoracic Epidural Analgesia and Incidence of Major Complications: a Large Retrospective Dual Center Experi-ence

Status: COMPLETED

Condition: Neuropathic Pain

Interventions: thoracic epidural for pain relief after major thoracic surgery and lung transplantation

Date: 2023-06-06